Lisinopril and Sprintec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and Sprintec (ethinyl estradiol; norgestimate). Common drug interactions include injury among females and angina pectoris among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Sprintec. It is created by eHealthMe based on reports of 98 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.



On Jul, 20, 2026

98 people who take Lisinopril and Sprintec together, and have interactions are studied.

Lisinopril and Sprintec drug interactions.

What are the common drug interactions of Lisinopril and Sprintec, by gender? *:

female:

  1. Injury
  2. Loss of consciousness
  3. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  4. Multiple allergies (allergy to multiple agents)
  5. Oropharyngeal pain
  6. Pneumonia
  7. Pruritus (severe itching of the skin)
  8. Retching (strong involuntary effort to vomit)
  9. Sinus pain
  10. Spinal pain (pain in spine)

male:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Back pain
  3. Hyperprolactinaemia (abnormally high levels of prolactin in the blood)
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  5. Limb injury
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Osteoporosis (bones weak and more likely to break)
  8. Plasma cell myeloma (cancer that begins in plasma cells)
  9. Post-traumatic stress disorder
  10. Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Lisinopril and Sprintec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Loss of consciousness
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  5. Thirst
  6. Abdominal pain lower
  7. Back pain
  8. Escherichia infection (bacterial infection by escherichia coli)
  9. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  10. Heart rate increased

20-29:

  1. Abnormal weight gain
  2. Abortion spontaneous (naturally occurring miscarriage)
  3. Acute sinusitis
  4. Alloimmunisation (alloimmunity is an immune response to foreign antigens (alloantigens) from members of the same species)
  5. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  6. Anxiety
  7. Arthralgia (joint pain)
  8. Asthenia (weakness)
  9. Bankruptcy
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

30-39:

  1. Fatigue (feeling of tiredness)
  2. Urinary tract infection
  3. Asthenia (weakness)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Chest pain
  6. Nasal discomfort
  7. Nasal dryness (dry nose)
  8. Pain
  9. Pulmonary function test decreased
  10. Respiratory syncytial virus infection (viral disease of respiratory system)

40-49:

  1. Ulcer
  2. Urinary tract infection
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. White blood cell count decreased
  5. Balance disorder
  6. Muscular weakness (muscle weakness)
  7. Nausea (feeling of having an urge to vomit)
  8. Anxiety
  9. Cough
  10. General physical health deterioration (weak health status)

50-59:

  1. Cystitis (inflammation of the wall of the bladder)
  2. Fatigue (feeling of tiredness)
  3. Hot flush (sudden feelings of heat)
  4. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  5. Nausea (feeling of having an urge to vomit)

60+:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Back pain
  3. Hyperprolactinaemia (abnormally high levels of prolactin in the blood)
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  5. Limb injury
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Osteoporosis (bones weak and more likely to break)
  8. Plasma cell myeloma (cancer that begins in plasma cells)
  9. Post-traumatic stress disorder
  10. Pulmonary embolism (blockage of the main artery of the lung)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 23 people, 23.47%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 14.29%
  3. Cystic Fibrosis (disease of the secretary glands): 11 people, 11.22%
  4. Pain: 9 people, 9.18%
  5. Nausea (feeling of having an urge to vomit): 8 people, 8.16%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 7.14%
  7. Depression: 7 people, 7.14%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 7.14%
  9. Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 6 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and Sprintec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lisinopril and Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lisinopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sprintec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisinopril and ethinyl estradiol; norgestimate (the active ingredients of Lisinopril and Sprintec, respectively), and Lisinopril and Sprintec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: